Key Trends Influencing the Growth of the Cell Banking Outsourcing Market in 2025: Innovative Single Cell Potency Characterization Platform Revolutionizes Cell Therapy Research

Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.

What Is the Expected CAGR for the Cell Banking Outsourcing Market Through 2025?
In recent times, the size of the cell banking outsourcing market has seen a significant increase. The market, which was valued at $11.19 billion in 2024, is projected to hit $12.89 billion in 2025, exhibiting a compound annual growth rate (CAGR) of 15.2%. This expansion during the historical period has been shaped by factors such as the surge in chronic ailment incidences, enhanced regulatory guidelines and governmental initiatives, as well as the expansion in banking services establishment.

What's the Projected Size of the Global Cell Banking Outsourcing Market by 2029?
The market size of cell banking outsourcing is predicted to experience swift expansion in the coming years, reaching a value of $22.39 billion in 2029 with a compound annual growth rate (CAGR) of 14.8%. This expected surge during the forecast period can be credited to the surge in uptake of cellular products, a growing need for monoclonal antibodies, increasingly popular stem cell treatments, an aging population, and a heightened reliance on cell-specific therapies. Key trends expected during this forecast period encompass innovative products, advancements in technology, increased investment in research and development, and partnerships formed between biotechnology firms and dedicated cell banking services.

View the full report here:
https://www.thebusinessresearchcompany.com/report/cell-banking-outsourcing-global-market-report

Top Growth Drivers in the Cell Banking Outsourcing Industry: What's Accelerating the Market?
The increasing prevalence of chronic diseases is anticipated to boost the expansion of the cell banking outsourcing market in the future. Chronic diseases are prolonged health conditions that typically grow over time and endure for an extended period. The surge in chronic diseases can be accredited to a range of factors, including lifestyle modifications, elder demographics, and genetic susceptibilities. Cell banking outsourcing is crucial in enhancing research and development initiatives targeted at combating chronic diseases. It offers access to expertise, resources, and facilities that might not be available internally. For instance, according to the Department of the Treasury, an Australia-based national treasury and financial department, in July 2023, it was found that in 2020-21, almost half of Australians of all age groups (46.6%) were suffering from one or more chronic diseases, and nearly one in five (18.6%) had two or more chronic conditions. Hence, the increasing burden of chronic diseases is fuelling the growth of the cell banking outsourcing market.

Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=15754&type=smp

What Trends Will Shape the Cell Banking Outsourcing Market Through 2029 and Beyond?
Leaders in the cell banking outsourcing market, such as Cellply Srl, are transforming the market by introducing cutting-edge technology like single-cell potency characterization platforms. These platforms provide in-depth and accurate analysis of individual cell potency within a population. Tracing back to January 2024, the Italian biotech corporation, Cellply Srl, unveiled VivaCyte, their primary product and a comprehensive single-cell potency characterization platform. VivaCyte merges immunophenotyping with potency analysis to promote efficiency in cell therapy research and development. It is a wholly automated platform that has single-cell precision and designed to decrease costs, development time, and risks by swiftly and thoroughly examining the intricate functionality and action mechanisms of potential cellular immunotherapies. This pioneering technology facilitates swift examination of numerous cell therapy options from an assortment of procedures on several target tumor cells, presenting consistent immune and single-cell functional characterization in less time than existing analytical devices.

What Are the Main Segments in the Cell Banking Outsourcing Market?
The cell banking outsourcing market covered in this report is segmented -

1) By Type: Master Cell Banking, Working Cell Banking, Viral Cell Banking
2) By Cell Type: Stem Cell Banking, Non-Stem Cell Banking
3) By Phase: Bank Storage, Bank Characterization And Testing, Bank Preparation

Subsegments:
1) By Master Cell Banking: Human Master Cell Bank, Animal Master Cell Bank
2) By Working Cell Banking: Human Working Cell Bank, Animal Working Cell Bank
3) By Viral Cell Banking: Virus Bank For Vaccine Production, Viral Vector Bank For Gene Therapy, Adenovirus Bank

Tailor your insights and customize the full report here:
https://www.thebusinessresearchcompany.com/customise?id=15754&type=smp

Which Top Companies are Driving Growth in the Cell Banking Outsourcing Market?
Major companies operating in the cell banking outsourcing market are LabCorp Drug Development, SGS Life Sciences, Lonza Group Ltd., WuXi AppTec, Charles River Laboratories, Sigma-Aldrich Co. Ltd., Covance Inc., Global Stem Inc., LifeCell, Cryoviva India, Sartorius AG, Bio Reliance, CordLife, Reliance Life Sciences, Cryo-Cell International Inc., Toxikon Corp., Cleancells, Clean Biologics, Texcell, PX'Therapeutics SA, Goodwin Biotechnology Inc., Transcell Biolife Pvt Ltd., Perfectus Biomed Limited, BioStorage Technologies Inc.

Which Regions Will Dominate the Cell Banking Outsourcing Market Through 2029?
North America was the largest region in the cell banking outsourcing market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the cell banking outsourcing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

Purchase the full report today:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=15754

This Report Supports:
1.Business Leaders & Investors - To identify growth opportunities, assess risks, and guide strategic decisions.
2.Manufacturers & Suppliers - To understand market trends, customer demand, and competitive positioning.
3.Policy Makers & Regulators - To track industry developments and align regulatory frameworks.
4.Consultants & Analysts - To support market entry, expansion strategies, and client advisory work.

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Europe: +44 7882 955267,
Asia: +91 88972 63534,
Americas: +1 310-496-7795 or
Email:info@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.